✦ LIBER ✦
O.079 Novel sustained release formulation of IFN α-2b improves tolerability and demonstrates potent viral load reduction in a phase I/II HCV clinical trial
✍ Scribed by C. Trépo; R. Meyrueix; M. Maynard; R. Rouzier; M. Bourliere; Y. Donazzolo; J. Zarski; R. Kravtzoff
- Book ID
- 117770123
- Publisher
- Elsevier Science
- Year
- 2006
- Tongue
- English
- Weight
- 129 KB
- Volume
- 36
- Category
- Article
- ISSN
- 1386-6532
No coin nor oath required. For personal study only.